Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Botox® (onabotulinumtoxinA) – Expanded indication
July 9, 2020 - AbbVie and Allergan announced the FDA approval of Botox (onabotulinumtoxinA), for the treatment of spasticity in patients 2 years of age and older.
